ICCR-Rossdorf GmbH is a contract research institute for genotoxicity testing and alternative toxicological methods. The company conducts experimental studies and prepares study reports for customers from the chemical, agrochemical, cosmetic and pharmaceutical industries as well as medical device manufacturers, which are used by regulatory authorities and for internal safety assessments. In 2022 a total of 848 toxicological studies were completed, of which 653 were GLP-mandatory and 195 were non‑GLP studies; additionally 320 GMP certificates for pharmaceutical end products were issued. The report describes the company as a well‑known, flexible niche player beyond Germany with more than 30 years of expertise, and its shares are 100% owned by CCR Group B.V., Amsterdam.
Die Durchführung von Untersuchungen zur Toxizität, Genotoxizität, Kanzerogenität und Teratogenität von physikalischen und chemischen Agenzien und Bioprodukten an höheren Zellen und Mikroorganismen einschließlich deren Bestandteilen, allgemeine Forschungsarbeiten mit allen Arten höheren Zellen, Zellverbänden und Mikroorganismen sowie Tätigkeiten in artverwandten Gebieten.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 6837 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Corinne Guicheney | Geschäftsführer(in) | Le Rouret |
| Alexander Kleinke | Geschäftsführer(in) | Hamburg |
| Markus Schulz | Geschäftsführer(in) | Bensheim |
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 6837 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2022 | €7,793,639 | €1,066,120 | €9,044,485 | 93 |
| 2021 | €7,568,013 | €1,185,322 | €7,341,298 | 87 |
| 2020 | €6,879,963 | €654,135 | €6,139,386 | 81 |
| 2019 | €6,653,673 | €358,491 | €6,455,005 | 83 |
| 2018 | — | -€350,527 | €4,351,355 | 91 |
| 2017 | — | €1,155,155 | €5,875,023 | 89 |
| 2016 | — | -€207,886 | €7,364,502 | 95 |
| 2015 | — | €735,171 | €5,206,920 | 101 |
| 2014 | €8,312,106 | €598,167 | €5,649,999 | 106 |
| 2013 | €9,822,451 | €1,269,200 | €6,619,185 | 117 |
Sign in to download data
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 6837 (as of 30 October 2026)
Sartorius Xell GmbH
Schloß Holte-Stukenbrock · Forschung und Entwicklung im Bereich Biotechnologie
Reaction Biology Europe GmbH
Freiburg im Breisgau · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
STÖRK Umwelttechnik GMBH
Emmingen-Liptingen · Forschung und Entwicklung im Bereich Biotechnologie
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €4,198,888 | 78.6% |
| Material Costs | €851,645 | 15.9% |
| Depreciation | €256,197 | 4.8% |
| Interest & Similar | €34,537 | 0.6% |
